Two widely used anti-DRα monoclonal antibodies bind to an intracellular C-terminal epitope

Human Immunology

Volumn 53, Issue 1, 1997, Pages 34-38

  Grüneberg, Ulrike ^a   Rich, Tina ^b   Roucard, Corinne ^a   Van Ham, S Marieke ^a   Charron, Dominique ^b   Trowsdale, John ^a,c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; IMMUNOBLOTTING; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; EPITOPES; HLA-DR ANTIGENS; HUMANS; INTRACELLULAR FLUID; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION;

EID: 0343051779     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00025-6     Document Type: Article

References (15)

1. Cresswell P: Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 12:259, 1994.
2. Rammensee H-G, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 41:178, 1995.
3. Lampson LA, Levy R: Two populations of Ia-like molecules on a human cell line. J Immunol 125:293, 1980.
4. Fu X, Karr RW: HLA DRα chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes. Hum Immunol 39:253, 1994.
5. Johnson JP, Meo T, Riethmuller G, Schendel DJ, Wank R: Direct determination of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3. J Exp Med 156:104, 1982.
6. Guy K, van Heyningen V, Cohen BB, Deane DL, Steel CM: Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha-chain and beta chain. Eur J Immunol 12:942, 1982.
7. Adams TE, Bodmer JG, Bodmer WF: Production and characterization of monoclonal antibodies recognizing the α-chain subunits of human Ia alloantigens. Immunology 50:613, 1983.
8. Guido M, Rugge M, Fattovich G, Murer B: HLA-DR expression in liver in human HIV infection. Liver 15:126, 1995.
9. Norton AJ, Isaacson PG: Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. Am J Pathol 128: 225, 1987.
10. Rowlinson G, Balkwill F, Snook D, Hooker G, Epenetos AA: Enhancement by gamma-interferon of in vivo tumour radiolocalization by a monoclonal antibody against HLA-DR antigen. Cancer Res 46:6413, 1986.
11. Garban F, Ericson M, Roucard C, Rabian-Herzog C, Teisserenc H, Sauvanet E, Charron D, Mooney N: Detection of empty HLA class II molecules on cord blood B cells. Blood 9:3970, 1996.
12. Warmerdam PAM, Long EO, Roche PA: Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 133:281, 1996.
13. Newcomb JR, Cresswell P: Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J Immunol 150:499, 1993.
14. Malcherek G, Gnau V, Stevanovic S, Rammensee H-G, Jung G, Melms A: Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J Immunol 153:1141, 1994.
15. Malcherek G, Gnau V, Jung G, Rammensee H-G, Melms A: Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med 181:527, 1995.